Tags |
|
|
Links |
|
|
Top Articles - Analyst Reports
When you become interested in a stock or mutual fund you can call your broker and he will send you reports on how the co
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
mpany is doing, what their management is like and what might be the projected earnings for the company and how the indus
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
try is doing. Great information.
You will apply yourself to this mound of papers to determine if you want to buy the eq
You will apply yourself to this mound of papers to determine if you want to buy the eq
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
uity. You might also send for more reports from independent analysts such as Morningstar. You will become buried in pape
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
rs. That is what the brokerage company wants. The reason is very simple. If you buy the stock after doing all that resea
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
rch and it goes down instead of up they are not responsible for your stupidity. Of course, if it goes up they can take c
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
redit for providing all that great information.
Now let's think for a minute. You received all that information that wa
Now let's think for a minute. You received all that information that wa
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
s already printed so it could be sent to you. It makes me ask when was that printed? How old is the information? If I ca
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
n get all this stuff about the company it means that anyone can. What it boils down to is the information is just that -
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
information and none of it will tell you that the stock will go up further because the whole world knows.
These brochu
These brochu
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
res are made to help you BUY not SELL. In my years of experience I call them a work of fiction. No brokerage company is
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
going to issue a bad report about a company at least until it is ready for bankruptcy and by then your investment dollar
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
s have disappeared.
I know your next question. If I can't rely on those reports how am I going to buy anything? There i
I know your next question. If I can't rely on those reports how am I going to buy anything? There i
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
s a better way. You will want to see the price action of the stock or mutual fund. All stocks undulate as they go up or
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
down and you want to know the major trend.
On the Internet you can go to a web site www.bigcharts.com and type in the s
On the Internet you can go to a web site www.bigcharts.com and type in the s
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ymbol of the stock or fund and request a weekly chart going back for about to 5 years. What you are interested in is wha
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
t is it doing during the past 6 months to one year. If the trend is up it is a buy and if the trend is down or sideways
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
don't buy it or if you own it sell. See how easy that is. Brokers and financial planners won't like it because it takes
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
all the mystery out of buying stock and they don't want you to know this simple procedure.
Analyst reports give you lot
Analyst reports give you lot
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
s of useless information, but will not tell if the stock will go up after you buy it. If it isn't going up don't buy it.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/118133/toparticles-Analyst-Reports.html">Analyst Reports</a>
BB link (for phorums):
[url=http://www.toparticles.org.ua/article/118133/toparticles-Analyst-Reports.html]Analyst Reports[/url]
Related Articles:
Your Online Newsroom: How to Give Reporters a Tip
Too Few Resume Responses?-Try These Ten Tips to Improve Results
5 Effective Tips For Successful Submission To Web Directories
Bookmark it:
|